고려대학교 의과대학 및 의과학연구지원센터 구성원이 아닌 경우에는 본인인증을 통하여 글을 작성할 수 있습니다.
- 본인인증 후 글을 작성할 수 있습니다.
내 명의의 휴대전화로 비밀번호를 재설정 할 수 있습니다.
Korea University Medical Center, Selected as a Group to Lead Precision Medicine
Which is One of the National Strategic Projects
Leading the Future of Medicine by Taking the Lead in $ 66,947,000 Scale
Two project groups (precision medicine based cancer diagnosis and therapy development group and precision medicine hospital information system (P-HIS) development group) of Korea University Medical Center were selected for precision medicine, which is one of the national strategic projects with about $66,947,000 investment ($ 54,251,000 from the government and $12,696,000 from the private sector), taking the lead in the fourth industrial revolution in the domestic medical sector.
The projects related to the national strategic project of precision medicine selected for Korea University Medical Center are precision medicine based cancer diagnosis and therapy development project group (hereinafter referred to as K-MASTER project group) led by professor Yeul-Hong Kim (Division of Oncology and Hematology, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine) and precision medicine hospital information system (P-HIS) development group) led by professor Sang-Heon Lee (Vice President for Medical Research, Division of Rehabilitation, Korea University Anam Hospital). Professor Yeul-Hong Kim takes the position of representative head of the two projects.
The project is expected to bring about a new paradigm in the national medical system by developing new cancer therapies based on precision medicine and establishing cloud-based hospital information system with ICT based on the support of 62.4 billion won from the government for the next 5 years. The medical industry expects that the project will vitalize the precision medicine by 2021 and can create a new market based on a medical information system which is in line with the fourth industrial revolution.
Precision medicine, which has become a hot topic recently, is the next generation medical paradigm where individual patients are more precisely classified and provided with customized and optimized medicine (prevention, diagnosis and treatment) based on genome, clinical information, lifestyle and information on habit. Already, advanced countries such as the US and the UK regard the precision medicine as a future strategic area and started aggressive investment in this area. As such precision medicine has emerged as a key to the future of medical industry. The Korean government started this project to support the creation of a new market and vitalize precision medicine at the government level as it recognizes that Korea’s ICT competitiveness is well received and medical technology is at the top level in the world.
Korea University Medical Center will complete the genome sequencing platform for cancer diagnosis and treatment based on precision medicine and establish the process that will verify the effect of clinical research on target therapy through profiled patients through this project. In addition, the center will establish cloud-based P-HIS and business model to widely distribute the system home and abroad.